DE000A2GS5D8
DE000A2GS5D8
Dermapharm Holding SE I
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.164.978.000 | 1.180.766.000 | 1.3% |
| Cost of Revenue | 382.050.000 | 413.696.000 | 7.6% |
| Gross Profit | 782.928.000 | 767.070.000 | 2.1% |
| 555.611.000 | 552.338.000 | 0.6% | |
| Operating Income | 227.317.000 | 214.732.000 | 5.9% |
| Pretax Income | 183.510.000 | 172.005.000 | 6.7% |
| Net Income Common Stockholders | 132.412.000 | 113.787.000 | 16.4% |
| -- | -- | -- | |
| -- | -- | -- |